NanoViricides Inc (NNVC)

[arvitar]

Two ingredients are lacking for there to be "trade secrets".

- First, there is nothing of commercial value (i.e. PROFITABLE) to protect by a trade secret.

- Second, in the imaginary universe in which NNVC gets a product to market in ten or twenty years from now, a "trade secret" doesn't stop the best minds in well-funded pharma from doing it better and entering the market. In stark contrast, a live patent would stop others from entering the market.

Ergo, the "trade secret" excuse is just another attempt by Seymour to swindle the investing public into believing that Diwan's worthless aging patent isn't of concern.